US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRACE THERAPEUTICS INC

3.60

+0.12003.45%

Post-market: 3.59-0.0100-0.28%19:31 EST

Volume:55.08K

Turnover:197.02K

Market Cap:55.71M

PE:-6.79

High:3.66

Open:3.51

Low:3.49

Close:3.48

52wk High:3.94

52wk Low:1.75

Shares:15.47M

Float Shares:9.35M

Volume Ratio:0.75

T/O Rate:0.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5300

EPS(LYR):-0.7916

ROE:-13.15%

ROA:-11.85%

PB:0.89

PE(LYR):-4.55

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Grace Therapeutics Updates Executive Severance and Change-in-Control Compensation Terms

Grace Therapeutics Unveils Data on Novel IV Nimodipine for Subarachnoid Hemorrhage

Grace Therapeutics to Participate in Craig-Hallum Alpha Select Conference

Grace Therapeutics Unveils Data on Novel IV Nimodipine for aSAH Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GRCE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRCE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRCE\",,,,,undefined,":{"symbol":"GRCE","market":"US","secType":"STK","nameCN":"GRACE THERAPEUTICS INC","latestPrice":3.6,"timestamp":1770411600000,"preClose":3.48,"halted":0,"volume":55077,"hourTrading":{"tag":"盘后","latestPrice":3.59,"preClose":3.6,"latestTime":"19:31 EST","volume":2355,"amount":8469.4206,"timestamp":1770424308526,"change":-0.01,"changeRate":-0.002778,"amplitude":0.002778},"delay":0,"changeRate":0.03448275862068969,"floatShares":9348500,"shares":15474000,"eps":-0.53,"marketStatus":"Market Closed","change":0.12,"latestTime":"02-06 16:00:00 EST","open":3.51,"high":3.66,"low":3.49,"amount":197019.9848595,"amplitude":0.048851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.53,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1357534800000,"exchange":"NASDAQ","adjPreClose":3.48,"preHourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.48,"latestTime":"08:35 EST","volume":3686,"amount":12863.90041,"timestamp":1770384940068,"change":0.02,"changeRate":0.005747,"amplitude":0.028736},"postHourTrading":{"tag":"盘后","latestPrice":3.59,"preClose":3.6,"latestTime":"19:31 EST","volume":2355,"amount":8469.4206,"timestamp":1770424308526,"change":-0.01,"changeRate":-0.002778,"amplitude":0.002778},"volumeRatio":0.7485301771702269,"impliedVol":2.4607,"impliedVolPercentile":0.1667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRCE\",,,,,undefined,":{"symbol":"GRCE","floatShares":9348500,"roa":"-11.85%","roe":"-13.15%","lyrEps":-0.791576,"volumeRatio":0.7485301771702269,"shares":15474000,"dividePrice":0,"high":3.66,"amplitude":0.048851,"preClose":3.48,"low":3.49,"week52Low":1.75,"pbRate":"0.89","week52High":3.938,"institutionHeld":0,"latestPrice":3.6,"eps":-0.53,"divideRate":0,"volume":55077,"delay":0,"ttmEps":-0.53,"open":3.51,"prevYearClose":3.46,"prevWeekClose":3.63,"prevMonthClose":3.63,"prevQuarterClose":3.46,"fiveDayClose":3.63,"twentyDayClose":3.8,"sixtyDayClose":2.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRCE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"GRCE","fiscalQuarterEnding":"2025/09","expectedEps":-0.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2025-08-12","symbol":"GRCE","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"","actualEps":-0.21},{"market":"US","date":"2025-06-23","symbol":"GRCE","fiscalQuarterEnding":"2025/03","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1750651200000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2025-02-13","symbol":"GRCE","fiscalQuarterEnding":"2024/12","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-11-13","symbol":"GRCE","fiscalQuarterEnding":"2024/09","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRCE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRCE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1746162000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRCE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRCE","date":"2026-02-05","current":-6.792453,"percent":0.028571,"low":-7.578711,"twenty":-4.624937,"median":-3.861639,"eighty":-2.76081,"high":-1.653321,"avg":-3.941283,"sd":1.475306,"marketCap":56944415},"quantilePoints":[{"date":"2024-10-31","current":-2.746009,"twenty":-2.84522,"median":-2.808016,"eighty":-2.770812,"marketCap":31433569},{"date":"2024-11-08","current":-2.737151,"twenty":-2.770812,"median":-2.746009,"eighty":-2.701719,"marketCap":31332170},{"date":"2024-11-15","current":-2.891861,"twenty":-2.815988,"median":-2.74158,"eighty":-2.694633,"marketCap":33562939},{"date":"2024-11-22","current":-2.821967,"twenty":-2.824979,"median":-2.746009,"eighty":-2.701719,"marketCap":32751751},{"date":"2024-11-29","current":-2.935545,"twenty":-2.870023,"median":-2.76081,"eighty":-2.701719,"marketCap":34069932},{"date":"2024-12-06","current":-3.791745,"twenty":-2.935545,"median":-2.823849,"eighty":-2.717126,"marketCap":44006996},{"date":"2024-12-13","current":-3.407329,"twenty":-3.407329,"median":-2.865651,"eighty":-2.737151,"marketCap":39545457},{"date":"2024-12-20","current":-3.547117,"twenty":-3.407329,"median":-2.887493,"eighty":-2.746009,"marketCap":41167835},{"date":"2024-12-27","current":-3.232594,"twenty":-3.39335,"median":-2.931176,"eighty":-2.746009,"marketCap":37517485},{"date":"2025-01-03","current":-3.494696,"twenty":-3.396845,"median":-2.953018,"eighty":-2.749647,"marketCap":40559444},{"date":"2025-01-10","current":-3.582064,"twenty":-3.494696,"median":-3.066596,"eighty":-2.755568,"marketCap":41573430},{"date":"2025-01-17","current":-2.935545,"twenty":-3.494696,"median":-3.057859,"eighty":-2.767291,"marketCap":34069932},{"date":"2025-01-24","current":-3.437907,"twenty":-3.492949,"median":-3.145227,"eighty":-2.786004,"marketCap":39900353},{"date":"2025-01-31","current":-2.778283,"twenty":-3.476349,"median":-3.13649,"eighty":-2.78702,"marketCap":32244757},{"date":"2025-02-07","current":-2.918071,"twenty":-3.433539,"median":-3.040386,"eighty":-2.785272,"marketCap":33867135},{"date":"2025-02-14","current":-3.040386,"twenty":-3.416065,"median":-3.038201,"eighty":-2.814977,"marketCap":35286716},{"date":"2025-02-21","current":-2.570989,"twenty":-3.416065,"median":-3.009807,"eighty":-2.777013,"marketCap":34374128},{"date":"2025-02-28","current":-2.29038,"twenty":-3.407329,"median":-2.996702,"eighty":-2.746009,"marketCap":30622380},{"date":"2025-03-07","current":-2.050724,"twenty":-3.407329,"median":-2.952538,"eighty":-2.701719,"marketCap":27418184},{"date":"2025-03-14","current":-1.736745,"twenty":-3.389855,"median":-2.935545,"eighty":-2.613138,"marketCap":23220281},{"date":"2025-03-21","current":-1.941514,"twenty":-3.363645,"median":-2.904966,"eighty":-2.495149,"marketCap":25958044},{"date":"2025-03-28","current":-2.329102,"twenty":-3.337435,"median":-2.883124,"eighty":-2.329102,"marketCap":31140100},{"date":"2025-04-04","current":-2.25728,"twenty":-3.328698,"median":-2.865651,"eighty":-2.3283,"marketCap":30179833},{"date":"2025-04-11","current":-1.99051,"twenty":-3.319961,"median":-2.825732,"eighty":-2.29038,"marketCap":26613125},{"date":"2025-04-17","current":-2.093114,"twenty":-3.278025,"median":-2.81323,"eighty":-2.187348,"marketCap":27984936},{"date":"2025-04-25","current":-2.441966,"twenty":-3.253562,"median":-2.777648,"eighty":-2.187348,"marketCap":32649092},{"date":"2025-05-02","current":-2.780558,"twenty":-3.243078,"median":-2.76081,"eighty":-2.203926,"marketCap":37176067},{"date":"2025-05-09","current":-2.872902,"twenty":-3.234341,"median":-2.778283,"eighty":-2.214186,"marketCap":38410696},{"date":"2025-05-16","current":-2.784047,"twenty":-3.204636,"median":-2.778283,"eighty":-2.249072,"marketCap":37222708},{"date":"2025-05-23","current":-3.04702,"twenty":-3.183669,"median":-2.787433,"eighty":-2.28376,"marketCap":40738659},{"date":"2025-05-30","current":-2.978583,"twenty":-3.159206,"median":-2.802024,"eighty":-2.29493,"marketCap":39823661},{"date":"2025-06-06","current":-3.037068,"twenty":-3.145227,"median":-2.825732,"eighty":-2.310491,"marketCap":40605593},{"date":"2025-06-13","current":-2.996026,"twenty":-3.145227,"median":-2.855425,"eighty":-2.319966,"marketCap":40056869},{"date":"2025-06-20","current":-3.149932,"twenty":-3.145227,"median":-2.867837,"eighty":-2.32375,"marketCap":42114585},{"date":"2025-06-27","current":-4.249161,"twenty":-3.190658,"median":-2.872902,"eighty":-2.328621,"marketCap":40655972},{"date":"2025-07-03","current":-4.523767,"twenty":-3.242086,"median":-2.883124,"eighty":-2.331154,"marketCap":43283399},{"date":"2025-07-11","current":-4.480408,"twenty":-3.326951,"median":-2.892641,"eighty":-2.341415,"marketCap":42868542},{"date":"2025-07-18","current":-4.841731,"twenty":-3.403834,"median":-2.918071,"eighty":-2.351675,"marketCap":46325682},{"date":"2025-07-25","current":-4.624937,"twenty":-3.433539,"median":-2.930636,"eighty":-2.361936,"marketCap":44251398},{"date":"2025-08-01","current":-4.176896,"twenty":-3.536633,"median":-2.935545,"eighty":-2.372196,"marketCap":39964544},{"date":"2025-08-08","current":-4.263614,"twenty":-3.615264,"median":-2.954985,"eighty":-2.392716,"marketCap":40794257},{"date":"2025-08-15","current":-4.12993,"twenty":-3.770777,"median":-2.969531,"eighty":-2.448122,"marketCap":42591970},{"date":"2025-08-22","current":-4.424925,"twenty":-4.171115,"median":-2.986997,"eighty":-2.477228,"marketCap":45634254},{"date":"2025-08-29","current":-4.00925,"twenty":-4.24627,"median":-2.996702,"eighty":-2.502733,"marketCap":41347400},{"date":"2025-09-05","current":-4.103112,"twenty":-4.234708,"median":-3.005439,"eighty":-2.533069,"marketCap":42315399},{"date":"2025-09-12","current":-4.317654,"twenty":-4.278067,"median":-3.026807,"eighty":-2.55483,"marketCap":44527969},{"date":"2025-09-19","current":-4.183566,"twenty":-4.278067,"median":-3.037068,"eighty":-2.570221,"marketCap":43145113},{"date":"2025-09-26","current":-4.12993,"twenty":-4.263614,"median":-3.042574,"eighty":-2.570989,"marketCap":42591970},{"date":"2025-10-03","current":-4.049477,"twenty":-4.249161,"median":-3.047328,"eighty":-2.593742,"marketCap":41762257},{"date":"2025-10-10","current":-4.049477,"twenty":-4.234708,"median":-3.057723,"eighty":-2.595872,"marketCap":41762257},{"date":"2025-10-17","current":-4.304246,"twenty":-4.234708,"median":-3.067849,"eighty":-2.613138,"marketCap":44389684},{"date":"2025-10-24","current":-4.223792,"twenty":-4.234708,"median":-3.088369,"eighty":-2.616494,"marketCap":43559970},{"date":"2025-10-31","current":-4.277428,"twenty":-4.249161,"median":-3.127753,"eighty":-2.626653,"marketCap":44113112},{"date":"2025-11-07","current":-4.472902,"twenty":-4.277428,"median":-3.147579,"eighty":-2.626653,"marketCap":46129039},{"date":"2025-11-14","current":-4.561183,"twenty":-4.285293,"median":-3.197647,"eighty":-2.667694,"marketCap":47039480},{"date":"2025-11-21","current":-5.673105,"twenty":-4.29252,"median":-3.241803,"eighty":-2.677955,"marketCap":44363684},{"date":"2025-11-28","current":-5.745374,"twenty":-4.304791,"median":-3.258804,"eighty":-2.688958,"marketCap":44928827},{"date":"2025-12-05","current":-5.926046,"twenty":-4.321299,"median":-3.328698,"eighty":-2.692631,"marketCap":46341683},{"date":"2025-12-12","current":-6.070584,"twenty":-4.338036,"median":-3.37675,"eighty":-2.699947,"marketCap":47471968},{"date":"2025-12-19","current":-6.628899,"twenty":-4.37129,"median":-3.407329,"eighty":-2.701719,"marketCap":51837987},{"date":"2025-12-26","current":-6.668474,"twenty":-4.381422,"median":-3.416065,"eighty":-2.710963,"marketCap":52147467},{"date":"2026-01-02","current":-6.846564,"twenty":-4.398844,"median":-3.485959,"eighty":-2.725136,"marketCap":53540129},{"date":"2026-01-09","current":-7.519348,"twenty":-4.414931,"median":-3.520906,"eighty":-2.740694,"marketCap":58801298},{"date":"2026-01-16","current":-7.202743,"twenty":-4.455514,"median":-3.582064,"eighty":-2.746009,"marketCap":56325454},{"date":"2026-01-23","current":-7.519348,"twenty":-4.480408,"median":-3.617011,"eighty":-2.747222,"marketCap":58801298},{"date":"2026-01-30","current":-6.945503,"twenty":-4.55824,"median":-3.673799,"eighty":-2.75382,"marketCap":54313831},{"date":"2026-02-05","current":-7.281895,"twenty":-4.624937,"median":-3.861639,"eighty":-2.76081,"marketCap":56944415}],"updateTime":1770444325130},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRCE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603529236","title":"Grace Therapeutics Updates Executive Severance and Change-in-Control Compensation Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2603529236","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603529236?lang=en_us&edition=fundamental","pubTime":"2026-01-13 06:01","pubTimestamp":1768255295,"startTime":"0","endTime":"0","summary":"Grace Therapeutics Inc. has amended its compensation agreements for key executives, including CEO Prashant Kohli and Principal Financial Officer Robert J. DelAversano. Under the new terms, if an executive is terminated without cause outside of a change in control, they will receive accrued salary and benefits, as well as a continuation of base salary and COBRA premium payments for six months, or twelve months for the CEO. In the event of a termination without cause or resignation for good reason within twelve months following a change in control, executives are entitled to a lump-sum payment equal to six months of base salary and target bonus, or eighteen months for the CEO, along with corresponding COBRA premium coverage. Additionally, all unvested equity awards will fully vest in connection with such terminations related to a change in control.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8tNp59:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRCE","BK4007"],"gpt_icon":0},{"id":"2588671532","title":"Grace Therapeutics Unveils Data on Novel IV Nimodipine for Subarachnoid Hemorrhage","url":"https://stock-news.laohu8.com/highlight/detail?id=2588671532","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588671532?lang=en_us&edition=fundamental","pubTime":"2025-12-01 05:55","pubTimestamp":1764539734,"startTime":"0","endTime":"0","summary":"Grace Therapeutics Inc. has provided an overview of its lead product candidate, GTx-104, a novel intravenous formulation of nimodipine designed for the treatment of aneurysmal subarachnoid hemorrhage . The company highlights unmet needs with the current standard of care, oral nimodipine, and positions GTx-104 as a potential alternative that may address oral delivery challenges. The pivotal Phase 3 STRIVE-ON safety trial met its primary endpoint, demonstrating clinical evidence of benefit compared to oral nimodipine. GTx-104 has received Orphan Drug Status, granting seven years of market exclusivity, and is supported by additional intellectual property protections. The New Drug Application  for GTx-104 was filed in June 2025 and accepted for review in August 2025, with a target Prescription Drug User Fee Act  date of April 23, 2026. You can access the full presentation through the link below.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251130:nNDL7nLpVP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRCE","BK4007"],"gpt_icon":0},{"id":"2584962557","title":"Grace Therapeutics to Participate in Craig-Hallum Alpha Select Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584962557","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584962557?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:03","pubTimestamp":1763384583,"startTime":"0","endTime":"0","summary":"Grace Therapeutics Inc. will participate in the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025, in New York. The company will present its clinical-stage, novel injectable formulation of nimodipine, GTx-104, which is being developed for IV infusion to address unmet medical needs in aneurysmal subarachnoid hemorrhage patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL3dM8G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRCE"],"gpt_icon":0},{"id":"2583551969","title":"Grace Therapeutics Unveils Data on Novel IV Nimodipine for aSAH Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2583551969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583551969?lang=en_us&edition=fundamental","pubTime":"2025-11-14 04:28","pubTimestamp":1763065701,"startTime":"0","endTime":"0","summary":"Grace Therapeutics Inc. has provided an update on GTx-104, its novel intravenous formulation of nimodipine, developed for the treatment of aneurysmal subarachnoid hemorrhage . GTx-104 is designed to address challenges associated with the oral administration of nimodipine, the current standard of care, by offering an intravenous option that may improve drug delivery and patient outcomes. The pivotal Phase 3 STRIVE-ON safety trial met its primary endpoint and demonstrated clinical evidence of benefit compared to the oral formulation. GTx-104 has been granted Orphan Drug Status, providing seven years of market exclusivity and additional intellectual property protection. The company filed a New Drug Application  for GTx-104 in June 2025, which was accepted for review in August 2025. The target Prescription Drug User Fee Act  date is set for April 23, 2026. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLb5hHxB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRCE","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GRCE\",params:#limit:6,delay:false,,,undefined,":[]}}